                         SEQUENCE LISTING

<110>  SPARK THERAPEUTICS, INC.
       QU, Guang
       LU, Lin
       WRIGHT, John  F.
 
<120>  SCALABLE METHODS FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRAL
       (AAV) VECTOR IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM 
       SUITABLE FOR CLINICAL USE

<130>  023637-0450382

<140>  PCT/US2016/64414
<141>  2016-12-01

<150>  US62/261,815
<151>  2015-12-01

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Forward primer

<400>  1
gcacaagctg gagtacaact a                                                 21


<210>  2
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Reverse primer

<400>  2
tgttgtggcg gatcttgaa                                                    19


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Probe

<400>  3
agcagaagaa cggcatcaag gtga                                              24


